138 related articles for article (PubMed ID: 35785873)
1. [Analysis of the development status and trend of vaccines in China's immunization program in the past decade].
Wang GJ; Shao ML
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Jun; 56(6):878-883. PubMed ID: 35785873
[TBL] [Abstract][Full Text] [Related]
2. The development of China's vaccine industry in the past decade: the perspective from drug regulatory science.
Wang G; Shao M
Hum Vaccin Immunother; 2021 Dec; 17(12):5666-5672. PubMed ID: 34856877
[TBL] [Abstract][Full Text] [Related]
3. The landscape of vaccines in China: history, classification, supply, and price.
Zheng Y; Rodewald L; Yang J; Qin Y; Pang M; Feng L; Yu H
BMC Infect Dis; 2018 Oct; 18(1):502. PubMed ID: 30286735
[TBL] [Abstract][Full Text] [Related]
4. Driving more WHO-recommended vaccines in the National Immunization Program: Issues and challenges in China.
Dai P; Wang Q; Jia M; Leng Z; Xie S; Feng L; Yang W
Hum Vaccin Immunother; 2023 Dec; 19(1):2194190. PubMed ID: 37099400
[TBL] [Abstract][Full Text] [Related]
5. Vaccine events raising public concern and associated immunization program policy and practice changes, China, 2005-2021.
Liu X; Yu W; Yin Z; Rodewald L; Song Y; Zhang Z; Ye J; Li L; Cao L; Cao L
Vaccine; 2022 Apr; 40(18):2561-2567. PubMed ID: 35339307
[TBL] [Abstract][Full Text] [Related]
6. Accelerating into Immunization Agenda 2030 with momentum from China's successful COVID-19 vaccination campaign during dynamic COVID Zero.
Rodewald LE
Infect Dis Poverty; 2023 Oct; 12(1):96. PubMed ID: 37845759
[TBL] [Abstract][Full Text] [Related]
7. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
[TBL] [Abstract][Full Text] [Related]
8. Improving Innovation and Access to Combination Vaccines for Childhood Immunization in China.
Ma J; Li Z; Sun Y; Liu Z; Dang Y; Huang Y
Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36497631
[TBL] [Abstract][Full Text] [Related]
9. Developing an effective and sustainable national immunisation programme in China: issues and challenges.
Chen S; Yao L; Wang W; Tang S
Lancet Public Health; 2022 Dec; 7(12):e1064-e1072. PubMed ID: 36252582
[TBL] [Abstract][Full Text] [Related]
10. An economic evaluation of the use of Japanese encephalitis vaccine in the expanded program of immunization of Guizhou province, China.
Yin Z; Beeler Asay GR; Zhang L; Li Y; Zuo S; Hutin YJ; Ning G; Sandhu HS; Cairns L; Luo H;
Vaccine; 2012 Aug; 30(37):5569-77. PubMed ID: 22698453
[TBL] [Abstract][Full Text] [Related]
11. How to address vaccine hesitancy? Lessons from National Hepatitis B Immunization Program in China.
Jiang H; Wei C
Front Public Health; 2024; 12():1286801. PubMed ID: 38317799
[TBL] [Abstract][Full Text] [Related]
12. Utilization pattern of Haemophilus influenza type b vaccine in eight provinces of China.
Li Y; Yue C; Wang Y; Zhu X; Martin K; Scherpbier RW; Liu J; Wang Z; Ma Y; Cheng H; Zhang Z; Wang Q; Li H; Xie S; Xiao Q; Wang H; An Z
Hum Vaccin Immunother; 2018 Apr; 14(4):894-899. PubMed ID: 29300680
[TBL] [Abstract][Full Text] [Related]
13. [Analysis on reported data of immunization monitoring system for category II vaccine in China, 2012].
Zheng JS; Cao L; Cao LS; Yuan P; Wang HQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Oct; 47(10):928-32. PubMed ID: 24378134
[TBL] [Abstract][Full Text] [Related]
14. A guideline for economic evaluations of vaccines and immunization programs in China.
Fang H; Chen C; Fang Y; He X; Hou Z; Jiang M; Jiang Y; Li S; Liu Y; Sui B; Sun Q; Wu J; Xu T; Yang J; Yin Z; Ying X; Yuan B; Zheng H; Zheng Y
Hum Vaccin Immunother; 2022 Nov; 18(6):2132802. PubMed ID: 36287462
[TBL] [Abstract][Full Text] [Related]
15. [Expert consensus on the use of combination vaccine and simultaneous immunization in children aged 0-12 months].
Immunization Service Guidance and Evaluation Committee, China Association for Vaccines
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Aug; 56(8):1035-1041. PubMed ID: 35922228
[TBL] [Abstract][Full Text] [Related]
16. Prioritization of Vaccines for Inclusion into China's Expanded Program on Immunization: Evidence from Experts' Knowledge and Opinions.
Ma C; Li J; Wang N; Wang Y; Song Y; Zeng X; Zheng C; An Z; Rodewald L; Yin Z
Vaccines (Basel); 2022 Jun; 10(7):. PubMed ID: 35891174
[TBL] [Abstract][Full Text] [Related]
17. [Expert consensus on the use of combination vaccine and simultaneous immunization in children aged 0-12 months].
China Vaccine Industry Association, Professional Committee for Guidance and Evaluation of Immunization Service
Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Aug; 43(8):1171-1177. PubMed ID: 35981977
[TBL] [Abstract][Full Text] [Related]
18. Vaccine-preventable disease control in the People's Republic of China: 1949-2016.
Yu W; Lee LA; Liu Y; Scherpbier RW; Wen N; Zhang G; Zhu X; Ning G; Wang F; Li Y; Hao L; Zhang X; Wang H
Vaccine; 2018 Dec; 36(52):8131-8137. PubMed ID: 30497834
[TBL] [Abstract][Full Text] [Related]
19. A review of China's compensation program for adverse reactions following immunization.
Yingxiong W
Front Public Health; 2023; 11():1211976. PubMed ID: 37608980
[TBL] [Abstract][Full Text] [Related]
20. [Vaccine loss related to the expanded immunization program in Xinjiang Uygur Autonomous Region, 2016-2017].
Guan J; Ma C; Ma HL; Wang HR; Liu SQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Dec; 40(12):1590-1594. PubMed ID: 32062921
[No Abstract] [Full Text] [Related]
[Next] [New Search]
